BECN1 and neoplasm: In the second stage, various miRNAs, including miRNA-30a, miRNA-376b and miRNA-519a, target Beclin1 and reduce the autophagy activity of tumor cells induced by cisplatin [33, 91], rapamycin [92], and imatinib [93].